Menu
GeneBe

rs759050645

Variant summary

Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1

The NM_001034850.3(RETREG1):c.22G>C(p.Glu8Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000159 in 1,444,730 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E8G) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00070 ( 1 hom., cov: 32)
Exomes 𝑓: 0.000095 ( 0 hom. )

Consequence

RETREG1
NM_001034850.3 missense

Scores

3
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: 1.69
Variant links:
Genes affected
RETREG1 (HGNC:25964): (reticulophagy regulator 1) The protein encoded by this gene is a cis-Golgi transmembrane protein that may be necessary for the long-term survival of nociceptive and autonomic ganglion neurons. Mutations in this gene are a cause of hereditary sensory and autonomic neuropathy type IIB (HSAN IIB), and this gene may also play a role in susceptibility to vascular dementia. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011]
RETREG1-AS1 (HGNC:55551): (RETREG1 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -7 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.0045346916).
BP6
Variant 5-16616950-C-G is Benign according to our data. Variant chr5-16616950-C-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 538124.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=2, Likely_benign=1}.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.000698 (106/151890) while in subpopulation AFR AF= 0.00255 (106/41516). AF 95% confidence interval is 0.00216. There are 1 homozygotes in gnomad4. There are 51 alleles in male gnomad4 subpopulation. This position pass quality control queck.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
RETREG1NM_001034850.3 linkuse as main transcriptc.22G>C p.Glu8Gln missense_variant 1/9 ENST00000306320.10
RETREG1-AS1NR_109946.1 linkuse as main transcriptn.561+464C>G intron_variant, non_coding_transcript_variant
RETREG1XM_011514053.4 linkuse as main transcriptc.22G>C p.Glu8Gln missense_variant 1/10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
RETREG1ENST00000306320.10 linkuse as main transcriptc.22G>C p.Glu8Gln missense_variant 1/91 NM_001034850.3 Q9H6L5-1
RETREG1-AS1ENST00000653650.1 linkuse as main transcriptn.329+464C>G intron_variant, non_coding_transcript_variant

Frequencies

GnomAD3 genomes
AF:
0.000698
AC:
106
AN:
151784
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00256
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000298
AC:
2
AN:
67192
Hom.:
0
AF XY:
0.00
AC XY:
0
AN XY:
39104
show subpopulations
Gnomad AFR exome
AF:
0.00253
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000951
AC:
123
AN:
1292840
Hom.:
0
Cov.:
29
AF XY:
0.0000787
AC XY:
50
AN XY:
635720
show subpopulations
Gnomad4 AFR exome
AF:
0.00238
Gnomad4 AMR exome
AF:
0.0000853
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000215
Gnomad4 SAS exome
AF:
0.0000146
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000376
Gnomad4 OTH exome
AF:
0.000225
GnomAD4 genome
AF:
0.000698
AC:
106
AN:
151890
Hom.:
1
Cov.:
32
AF XY:
0.000687
AC XY:
51
AN XY:
74244
show subpopulations
Gnomad4 AFR
AF:
0.00255
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.000824
ExAC
AF:
0.0000459
AC:
1

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Neuropathy, hereditary sensory and autonomic, type 2B Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingBaylor GeneticsJan 29, 2018This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -
not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingInvitaeOct 01, 2022This sequence change replaces glutamic acid, which is acidic and polar, with glutamine, which is neutral and polar, at codon 8 of the RETREG1 protein (p.Glu8Gln). This variant is present in population databases (rs759050645, gnomAD 0.2%). This variant has not been reported in the literature in individuals affected with RETREG1-related conditions. ClinVar contains an entry for this variant (Variation ID: 538124). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsFeb 26, 2024This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.099
BayesDel_addAF
Benign
-0.55
T
BayesDel_noAF
Benign
-0.57
Cadd
Benign
17
Dann
Benign
0.96
DEOGEN2
Benign
0.0053
T
Eigen
Benign
-0.64
Eigen_PC
Benign
-0.65
FATHMM_MKL
Benign
0.041
N
LIST_S2
Benign
0.49
T
M_CAP
Benign
0.053
D
MetaRNN
Benign
0.0045
T
MetaSVM
Benign
-1.0
T
MutationTaster
Benign
1.0
N
PrimateAI
Pathogenic
0.82
D
PROVEAN
Benign
-0.27
N
REVEL
Benign
0.043
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
0.33
B
Vest4
0.086
MutPred
0.14
Gain of catalytic residue at E8 (P = 0.0193);
MVP
0.48
MPC
0.32
ClinPred
0.26
T
GERP RS
3.0
Varity_R
0.097
gMVP
0.25

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs759050645; hg19: chr5-16617059; API